Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 340 - SPEED: SPAAC SESSION III
Type: Topic-Contributed
Date/Time: Thursday, August 12, 2021 : 10:00 AM to 11:50 AM
Sponsor: Biopharmaceutical Section
Abstract #318770
Title: A Structured Framework for Bayesian Sequential Monitoring in Clinical Trials
Author(s): Evan Kwiatkowski* and Matthew Psioda and Eugenio Andraca-Carrera and Mat Soukup
Companies: University of North Carolina at Chapel Hill and UNC Chapel Hill and FDA and U.S. Food and Drug Administration
Keywords: Adaptive Trial Design; Bayesian Sequential Monitoring; Information Borrowing; Pediatric Trials
Abstract:

We present a Bayesian framework for sequential monitoring that allows for use of external data, and that can be applied in a wide range of clinical trial applications. The basis for this framework is the idea that, in many cases, specification of priors used for sequential monitoring and the stopping criteria can be semi-algorithmic byproducts of the trial hypotheses and relevant external data, simplifying the process of prior elicitation. Monitoring priors are defined using the family of generalized normal distributions which comprise a flexible class of priors, naturally allowing one to construct a prior that is peaked or flat about the parameter values thought to be most likely. External data are incorporated into the monitoring process though mixing an a priori skeptical prior with an enthusiastic one using a weight that can be fixed or adaptively estimated based on the degree to which observed data are better supported by a skeptical perspective versus an enthusiastic one. Preposterior analysis of each trial design is performed to illustrate that the proposed Bayesian approaches provide reasonable frequentist operating characteristics without having that explicit focus.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2021 program